![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Women don’t receive the same treatment as men for heart disease the world-over
Women with acute coronary syndrome (ACS) receive inferior or less aggressive treatment compared to...
Advances in personalized medicine for lung cancer
Several new studies that may help doctors tailor lung cancer treatment to the characteristics...
Abbott reports positive levodopa-carbidopa intestinal gel study data
Abbott has announced the Phase 3 study results of its levodopa-carbidopa intestinal gel (LCIG),...
VistaGen signs licensing deal for stem cell culture technology
VistaGen Therapeutics has signed a licensing agreement with the McEwen Centre for Regenerative Medicine...
UCLA-engineered stem cells seek out and kill HIV in living organisms
Expanding on previous research providing proof-of-principal that human stem cells can be genetically engineered...
Takeda to Acquire URL Pharma
Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to...
Alzheimer’s precursor protein controls its own fate
A research team led by the University of South Florida Department of Psychiatry &...
Amgen to acquire privately held KAI Pharmaceuticals
Amgen (NASDAQ: AMGN) and KAI Pharmaceuticals today announced an agreement under which Amgen will...
Indian government to address pharma industry issues
The task force, set up by the Union health ministry in India, has recommended...
Purdue Pharma announces availability of insomnia drug
Purdue Pharma has announced the availability of Intermezzo sublingual tablet CIV in 1.75mg and...